Convertible Debenture

Prospera Energy increased its non-brokered convertible debenture offering to CAD $4.0 million, targeting a close date on or before December 14, 2025, pending TSXV approval. Proceeds will fund well reactivation, production optimization, and working capital. The debenture includes a 12% interest rate and conversion options into units at CAD $0.05/$0.10, with warrants. Prospera will also issue 1,000,000 shares to settle $82,144 in payables. While the offering aims to boost production, investors face potential dilution from conversion features and share issuance.

Defence Therapeutics (DTCFF) announced a non-brokered private placement to raise up to $1.2 million by offering debenture units priced at $1,000 each. Each unit includes an 8% convertible debenture (convertible at $0.60 per share) maturing in two years and 1,666 common share purchase warrants (exercisable at $0.75 per share for two years). Interest will be paid annually in cash or shares at the company’s discretion. Securities are subject to a four-month hold. The offering aims to fund the company’s antibody-drug conjugate (ADC) programs.